Home › Glioma › Illinois › Chicago

Pag-aaral pangklinika para sa Glioma sa Chicago, IL

Isang pag-aaral para sa Glioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Nagre-recruitPhase 1/2

Research Site, Chicago

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05417594

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Nagre-recruitPhase 1/2

University of Chicago Comprehensive Cancer Center, Chicago

12 Months – 21 Years · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05099003

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nagre-recruitPhase 2

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Nagre-recruitPhase 1

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT04485559

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Nagre-recruitPhase 1

Northwestern Medicine, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07464925

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Nagre-recruitPhase 1/2

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Edad 1 hanggang 26 · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06712875

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Nagre-recruitPhase 1/2

Northwestern Memorial Hospital, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06810544

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Nagre-recruitPhase 1

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago

12 Months – 18 Years · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT04943848

Pag-aaral para sa Glioma sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.